Roche Drops Patent From Suits Over Generic Boniva
A patent covering the composition of Hoffmann-La Roche Inc.'s Boniva has now been dropped from all lawsuits seeking to stop generic companies from making their own version of the osteoporosis drug....To view the full article, register now.
Already a subscriber? Click here to view full article